Efficacy of green tea extract in the treatment of the patients with dry eye.
- Conditions
- Dry eye.Diseases of the eye and adnexa
- Registration Number
- IRCT2014042117374N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Incliusion criteria included? Dry eye and meibomian gland dysfunction.
Exclusion criteria included? Use of oral tetracyclines and corticosteroids in 3 months before study and all ophthalmic medication in one month before, Patients with other ocular surface disorders such as corneal surface damage, eyelid complications except blepharitis, any previous ocular surgery, history of drug allergy in eye , use of ophthalmic medication to treat other ophthalmic complication except dry eye and blepharitis, severe belepharitis and dry eye that require systemic treatment, Nasolacrimal duct system disorders such as punctal occlusion, Pregnancy and lactation, as well as patients taking systemic medications and systemic diseases affecting this study are excluded.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptom. Timepoint: Before the intervention, one month after the intervention. Method of measurement: The questionnaire included: symptoms of itching, Burning, Reduced vision, Foreign body sensation, Pains, photophobia, Redness.;Tear production. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Shirmer test.;Tear film stability. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Tear Film Brake Up Time test.;Ocular surface health. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Staining of the cornea and conjunctiva.;Meibomian glangd safety. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Color and quality of gland secretion.
- Secondary Outcome Measures
Name Time Method Drug allergy. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Clinical symptom.;Eye infection. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Clinical symptom.